优势产品

• Netarsudil(Mesylate) (Netarsudil(Mesylate)) (Catalog# : 712181, Cas# : 1422144-42-0) Netarsudil( AR-11324) is a Rho-associated protein kinase inhibitor. Netarsudil is potential useful for treating glaucoma and​/or reducing intraocular pressure. Netarsudil Increas
• 恩曲替尼 (Entrectinib(RXDX-101)) (Catalog# : 100504, Cas# : 1108743-60-7) Entrectinib (RXDX-101) is a selective inhibitor for all three TRK receptor tyrosine kinases encoded by the three NTRK genes, as well as the ROS1 and ALK receptor tyrosine kinases.
• JPH203 HCl (JPH203 HCl) (Catalog# : 18381, Cas# : 1597402-27-1) JPH203,也称为KYT- 0353,是一个强有力的和选择性(l型氨基酸转运蛋白1)的LAT1选择性抑制剂。JPH203可以很有说服力地抑制l-leucine吸收。
• ARRY-797 (ARRY-797 (ARRY-371797)) (Catalog# : 191112, Cas# : 1036404-17-7) NEWARRY-797 (ARRY-371797) is an oral, selective p38 mitogen-activated protein kinase inhibitor.
• lumateperone(Tosylate) (lumateperone(Tosylate)) (Catalog# : 17012102, Cas# : 1187020-80-9) Lumateperone (ITI-722/ITI-007)是一种新型的双5HT2A受体拮抗剂/多巴胺磷蛋白调制器(DPPM)，用于精神分裂症。
• SCR7 pyrazine (SCR7 pyrazine) (Catalog# : 1712261, Cas# : 14892-97-8) NEWSCR7吡嗪是DNA连接酶IV的小分子抑制剂,防止非同源端连接通过干扰连接酶结合和激活细胞凋亡。
• eCF506 (eCF506 ) (Catalog# : 18382, Cas# : 1914078-41-3) eCF506靶向一种叫做Src酪氨酸激酶的分子，这是乳腺癌细胞生长和传播所必需的。eCF506可能对阻止乳腺癌细胞的生长非常有效。
• Esaxerenone (Esaxerenone) (Catalog# : 1710121, Cas# : 1632006-28-0) Esaxerenone（cs-3150，xl-550）是一种非甾体类抗盐皮质激素Exelixis发现的，现在由Daiichi Sankyo公司发展为高血压，治疗高血压病，醛固酮增多症和糖尿病肾病。它作为一个具有高度选择性的沉默拮抗盐皮质激素受体（MR）、醛固酮受体，大于1000倍的选择性受体在其他类固醇激素的受体，并对MR相对于现有的antiminera
• BMS-777607 (BMS-777607) (Catalog# : 121417, Cas# : 1025720-94-8; 1196681-44-3) NEWBMS-777607 is an inhibitor of MET tyrosine kinase with potential antineoplastic activity. MET tyrosine kinase inhibitor BMS-777607 binds to c-Met protein, or hepatocyte growth fa
• Copanlisib HCl (Copanlisib HCI) (Catalog# : 18351, Cas# : 1402152-13-9) Copanlisib也称为BAY 80 - 6946,是一个强有力的磷酸肌醇3-激酶(PI3K)抑制剂。Copanlisib抑制PI3K信号通路的激活,起到抑制肿瘤细胞生长和生存的敏感肿瘤细胞群的作用。
• Nelotanserin (Nelotanserin) (Catalog# : 191121, Cas# : 839713-36-9) Nelotanserin( APD125) is a potent and selective human 5-hydroxytryptamine2A inverse agonist for the treatment of insomnia.
• Cenicriviroc (Cenicriviroc) (Catalog# : 179139, Cas# : 497223-25-3) Cenicriviroc(TAK-652, TBR-652) 是一种CCR2和CCR5受体抑制剂，临床上它被用于艾滋病的治疗。
• PTI-428(PTI428) (PTI-428(PTI428)) (Catalog# : 193211, Cas# : 1953130-87-4) NEWPTI-428是一种研究性CFTR放大器，开发用于治疗CFTR基因中发生F508del突变纯合的CF患者，作为获批CFTR调制剂的附加疗法，或作为PTI专有三联疗法的一部分，联合用药包括：增效剂PTI -808和校正剂PTI-801。PTI-428在CFTR生物合成的早期发挥作用，增加新合成CFTR蛋白质的水平，提示与CFTR校正剂和增效剂联合使用的潜在
• WWL70 (WWL70) (Catalog# : 16122847, Cas# : 947669-91-2) WWL70 is selective ABHD6 inhibitor, and it has shown anti-inflammatory and neuroprotective effects in animal models of traumatic brain injury and multiple sclerosis.
• Elenbecestat(E2609) (Elenbecestat(E2609)) (Catalog# : 2017878, Cas# : 1388149-30-1) NEWElenbecestat,也称为E2609，是一种阿尔茨海默氏症抑制剂。
• VU0467154 (VU0467154) (Catalog# : 18576, Cas# : 1451993-15-9) NEWVU0467154是一种有效的和选择性的M4 PAM.
• Tafenoquine (Tafenoquine) (Catalog# : 191122, Cas# : 106635-80-7) NEWTafenoquine is being investigated as a potential treatment for malaria, as well as for malaria prevention.
• KI-696 (KI-696) (Catalog# : 1710132, Cas# : 1799974-70-1) ki-696代表一个优良的低分子量的工具来研究体内Keap1与Nrf2-Nrf2的相互作用。在FBS中发现，在体外实验中显示出良好的效果，并显示出良好的体内效应。
• L-778123 (L-778123) (Catalog# : 1711249, Cas# : 183499-57-2) L-778,123 is an inhibitor of FPTase and GGPTase-I.
• Tafenoquine succinate (Tafenoquine succinate) (Catalog# : 191123, Cas# : 106635-81-8) Tafenoquine is being investigated as a potential treatment for malaria, as well as for malaria prevention.
• 更多  >>